Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS

Amyotrophic lateral sclerosis (ALS) causes motor neuron degeneration, paralysis, and death. Accurate disease modeling, identifying disease mechanisms, and developing therapeutics is urgently needed. We previously reported motor neuron toxicity through postmortem ALS spinal cord-derived astrocytes. H...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 111; no. 2; pp. 829 - 832
Main Authors: Meyer, Kathrin, Ferraiuolo, Laura, Miranda, Carlos J., Likhite, Shibi, McElroy, Sohyun, Renusch, Samantha, Ditsworth, Dara, Lagier-Tourenne, Clotilde, Smith, Richard A., Ravits, John, Burghes, Arthur H., Shaw, Pamela J., Cleveland, Don W., Kolb, Stephen J., Kaspar, Brian K.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences 14-01-2014
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Amyotrophic lateral sclerosis (ALS) causes motor neuron degeneration, paralysis, and death. Accurate disease modeling, identifying disease mechanisms, and developing therapeutics is urgently needed. We previously reported motor neuron toxicity through postmortem ALS spinal cord-derived astrocytes. However, these cells can only be harvested after death, and their expansion is limited. We now report a rapid, highly reproducible method to convert adult human fibroblasts from living ALS patients to induced neuronal progenitor cells and subsequent differentiation into astrocytes (i-astrocytes). Non-cell autonomous toxicity to motor neurons is found following coculture of i-astrocytes from familial ALS patients with mutation in superoxide dismutase or hexanucleotide expansion in C9orf72 (ORF 72 on chromosome 9) the two most frequent causes of ALS. Remarkably, i-astrocytes from sporadic ALS patients are as toxic as those with causative mutations, suggesting a common mechanism. Easy production and expansion of i-astrocytes now enables rapid disease modeling and high-throughput drug screening to alleviate astrocyte-derived toxicity.
Bibliography:http://dx.doi.org/10.1073/pnas.1314085111
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by Huda Y. Zoghbi, Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, and approved November 26, 2013 (received for review July 27, 2013)
Author contributions: K.M., L.F., C.J.M., S.J.K., and B.K.K. designed research; K.M., L.F., C.J.M., S.L., S.M., C.L.-T., R.A.S., S.J.K., and B.K.K. performed research; K.M., S.R., D.D., R.A.S., J.R., P.J.S., D.W.C., S.J.K., and B.K.K. contributed new reagents/analytic tools; K.M., L.F., C.J.M., D.D., C.L.-T., A.H.B., D.W.C., S.J.K., and B.K.K. analyzed data; and K.M., L.F., C.J.M., D.D., P.J.S., D.W.C., and B.K.K. wrote the paper.
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.1314085111